SCHEMBL23637659

SCHEMBL23637659

C=C(C)C(=O)Oc1ccc2c(c1)-c1ccccc1C2=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 2/20 0.51
S100A4 P26447 1/20 0.47
MAPT P10636 6/20 0.46
ALDH1A1 P00352 5/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
KMT2A Q03164 4/20 0.44
ATM Q13315 1/20 0.44
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
MEN1 O00255 1/20 0.42
MAOA P21397 1/20 0.42
PTPRC P08575 2/20 0.41
LMNA P02545 1/20 0.40
TTR P02766 1/20 0.39
STAT3 P40763 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRB1 P18505 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10489364 0.95 ELANE (0.53) ELANES100A4MAPTALDH1A1SMN1; SMN2
SCHEMBL22353034 0.85 ELANE (0.51) ELANES100A4MAPTALDH1A1SMN1; SMN2
SCHEMBL16939667 0.84 KMT2A (0.43) ELANEMAPTALDH1A1SMN1; SMN2KMT2A
SCHEMBL22345623 0.81 ELANE (0.49) ELANEMAPTALDH1A1SMN1; SMN2KMT2A
SCHEMBL4642778 0.81 MAPT (0.61) ELANES100A4MAPTALDH1A1SMN1; SMN2
SCHEMBL17717380 0.80 ELANE (0.49) ELANEMAPTALDH1A1SMN1; SMN2KMT2A
SCHEMBL22352933 0.80 ELANE (0.47) ELANEMAPTALDH1A1SMN1; SMN2KMT2A
Anthraquinone SCHEMBL17448113 0.79 ELANE (0.56) ELANEMAPTALDH1A1SMN1; SMN2KMT2A
SCHEMBL15085173 0.79 MAPT (0.62) ELANEMAPTALDH1A1SMN1; SMN2KMT2A
Hydrogen Sulfide SCHEMBL27822874 0.79 ELANE (0.55) ELANEMAPTALDH1A1SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214297-A1 METHOD FOR PREPARING KETO-FUNCTIONALIZED AROMATIC (METH)ACRYLATES EVONIK OPERATIONS GMBH (DE) 2021-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210214297-A1 METHOD FOR PREPARING KETO-FUNCTIONALIZED AROMATIC (METH)ACRYLATES ALKBH3, ALKBH5, ACR ELANE 4235/4885S100A4 2508/4885MAPT 1067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.